Going to run either way as GLP was de risked from the quarterly as they have done their own non GLP safety studies while they did their pre clinical studies
Walter Reed is de risked from previous pre clinical work hence 5-10 million in additional funding and partnership with US Army will be officialised in next 3 months
Phase 1 will be de risked from GLP coming up in next 4 weeks and because it’s an acute medication not chronic safety profile in humans improves significantly
This is like it’s peers north of 100 million market cap heading into phase 2 and FDA phase 2 approval after phase 1 coming up
The future is very bright let it run it’s course over the period ahead and news flow coming in
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.03M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 22143 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 682527 | 2 |
View Market Depth
| Last trade - 10.17am 31/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |
Day chart unavailable